Publication: Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs
Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs
Date
Date
Date
Citations
Brozy, J., Schlaepfer, E., Mueller, C. K. S., Rochat, M.-A., Rampini, S. K., Myburgh, R., Raum, T., Kufer, P., Baeuerle, P. A., Muenz, M., & Speck, R. F. (2018). Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs. Journal of Virology, 92(14), 1–13. https://doi.org/10.1128/JVI.00491-18
Abstract
Abstract
Abstract
Today's gold standard in HIV therapy is combined antiretroviral therapy (cART). It requires strict adherence by patients and lifelong medication, which can lower the viral load below detection limits and prevent HIV-associated immunodeficiency but cannot cure patients. The bispecific T cell-engaging (BiTE) antibody technology has demonstrated long-term relapse-free outcomes in patients with relapsed and refractory acute lymphocytic leukemia. Here, we generated BiTE antibody constructs that target the HIV-1 envelope protein gp120 (HIV
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Brozy, J., Schlaepfer, E., Mueller, C. K. S., Rochat, M.-A., Rampini, S. K., Myburgh, R., Raum, T., Kufer, P., Baeuerle, P. A., Muenz, M., & Speck, R. F. (2018). Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs. Journal of Virology, 92(14), 1–13. https://doi.org/10.1128/JVI.00491-18